Progressive Care Announces Shareholder Conference Call and Business Update on August 11, 2022
August 05 2022 - 7:15AM
InvestorsHub NewsWire
MIAMI, FL -- Aug. 05, 2022 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD), a personalized healthcare services and technology
company (the “Company” or “Progressive Care”), is pleased to
announce that the Company has scheduled an investor conference call
at 4:30 PM ET on Thursday, August 11, 2022.
Chairman and CEO, Alan Jay Weisberg, stated, “We are looking
forward to updating you on the results of the second quarter, our
prescription growth, and recent developments that we believe will
continue to accelerate our growth as a diversified
technology-centric healthcare organization”.
Those attending the investor conference call will have the
opportunity to submit questions concerning the Company to Stuart
Smith of SmallCapVoice.Com, Inc. via e-mail: ssmith@smallcapvoice.com by 12:00 PM EST on
Wednesday, August 10th, 2022. The Company plans to address as many
appropriate questions as possible.
To access the call:
Dial-In Number: 1-857-232-0157
Access Code: 422095
For those unable to participate in the live conference call, a
replay will be available at https://www.smallcapvoice.com/clients/rxmd/.
shortly after the call has concluded.
An archived version of the webcast will also be
available https://progressivecareus.com/news-releases/.
Progressive Care Inc.
Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
PharmcoRx
https://www.pharmcorx.com/
ClearMetrX
https://www.clearmetrx.com/
Forward-Looking Statements:
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
When used herein, the words “anticipate,” “believe,” “estimate,”
“upcoming,” “plan,” “target,” “intend” and “expect” and similar
expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company’s actual results, performance, prospects,
and opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Investor Relations Contact:
ClearThink Capital
nyc@clearthink.capital
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2023 to Apr 2024